Treatment of melanoma cells expressing non-specific shRNA with C2 ceramide increased PPAR-responsive firefly-luciferase reporter activity compared with vehicle-treated cells expressing non-specific shRNA (Figure 5F). Here, PPARA is linked to melanoma.